Re: Duration of Androgen Suppression before Radiotherapy for Localized Prostate Cancer: Radiation Therapy Oncology Group Randomized Clinical Trial 9910 Editorial Comment

被引：0
|
作者：
Taneja, Samir S.
机构：
来源：
JOURNAL OF UROLOGY | 2016年 / 195卷 / 01期
关键词：
D O I：
10.1016/j.juro.2015.10.057
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：96 / 96
页数：1
相关论文
共 50 条
  • [21] ANDROGEN DEPRIVATION WITH RADIATION-THERAPY COMPARED WITH RADIATION-THERAPY ALONE FOR LOCALLY ADVANCED PROSTATIC-CARCINOMA - A RANDOMIZED COMPARATIVE TRIAL OF THE RADIATION-THERAPY ONCOLOGY GROUP - EDITORIAL COMMENT
    SOLOWAY, MS
    UROLOGY, 1995, 45 (04) : 623 - 623
  • [22] Re: Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2018, 199 (03): : 609 - 609
  • [23] Is 6 months of androgen suppression therapy plus radiotherapy of benefit in patients with localized prostate cancer?
    Pollack, A
    Horwitz, EM
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (01): : 12 - 13
  • [24] Is 6 months of androgen suppression therapy plus radiotherapy of benefit in patients with localized prostate cancer?
    Alan Pollack
    Eric M Horwitz
    Nature Clinical Practice Oncology, 2005, 2 : 12 - 13
  • [25] Timing of androgen-deprivation therapy and radical radiotherapy in localized prostate cancer: a phase III randomized controlled trial
    Nieder, Carsten
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (08) : 738 - 739
  • [26] FAST-NEUTRON RADIOTHERAPY FOR LOCALLY ADVANCED PROSTATE-CANCER - FINAL REPORT OF A RADIATION-THERAPY ONCOLOGY GROUP RANDOMIZED CLINICAL-TRIAL
    LARAMORE, GE
    KRALL, JM
    THOMAS, FJ
    RUSSELL, KJ
    MAOR, MH
    HENDRICKSON, FR
    MARTZ, KL
    GRIFFIN, TW
    DAVIS, LW
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1993, 16 (02): : 164 - 167
  • [27] Re: Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer Editorial Comment
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2017, 198 (01): : 100 - 101
  • [28] A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902
    Rosenthal, Seth A.
    Hunt, Daniel
    Sartor, Oliver
    Pienta, Kenneth J.
    Gomella, Leonard
    Grignon, David
    Rajan, Raghu
    Kerlin, Kevin J.
    Jones, Christopher U.
    Dobelbower, Michael
    Shipley, William U.
    Zeitzer, Kenneth
    Hamstra, Daniel A.
    Donavanik, Viroon
    Rotman, Marvin
    Hartford, Alan C.
    Michalski, Jeffrey
    Seider, Michael
    Kim, Harold
    Kuban, Deborah A.
    Moughan, Jennifer
    Sandler, Howard
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (02): : 294 - 302
  • [29] Radiation Therapy and Androgen Deprivation in the Management of High Risk Prostate Cancer EDITORIAL COMMENT
    Heyns, C. F.
    INTERNATIONAL BRAZ J UROL, 2011, 37 (02): : 176 - 177
  • [30] Re: Intensity-Modulated Radiation Therapy, Proton Therapy, or Conformal Radiation Therapy and Morbidity and Disease Control in Localized Prostate Cancer Editorial Comment
    Penson, David F.
    JOURNAL OF UROLOGY, 2012, 188 (06): : 2230 - 2231
12345